This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Basal Insulin Therapy Module 1: Efficacy and Safety of Basal Insulin in Patients with Type 2 Diabetes

Basal Insulin Therapy Module 1: Efficacy and Safety of Basal Insulin in Patients with Type 2 Diabetes

Format

Slide Lecture Series

Time to Complete

1 hour

Released

December 22, 2017

Expires

December 31, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Pharmacy Credits

Pharmacists may earn 1.00 CPE Credits (0.10 CEUs) by completing this course on the American Society of Health-System Pharmacists (ASHP) website. Please click here to go to the course (you will leave the myCME website, and free registration on the ASHP website is required). Your certificate will save on ASHP.org and will not be included in your myCME CME History.

Accredited Provider

This continuing medical education activity is provided by the American Society of Health-System Pharmacists (ASHP).

Commercial Supporter

Supported by an educational grant from Novo Nordisk Inc.

Program Description

Insulin is often required in many patients with type 2 diabetes mellitus because of disease progression and the loss of pancreatic β-cell insulin secretion. Ideally, exogenously administered insulin mimics the physiologic profile of endogenous insulin secretion in healthy persons. New insulin formulations have been developed to improve the physiologic profile in patients with diabetes, which may decrease the risk of hypoglycemia and weight gain. In this online educational activity, the faculty sets the stage for the second module in the series by reviewing the efficacy and safety of basal insulin in managing type 2 diabetes, focusing on newer insulin therapies. Evidence from clinical trials supporting glycemic and cardiovascular benefits of diabetes therapies is reviewed, and the clinical profiles of different insulin products are compared with respect to dosing, variability, volume, and safety.

Intended Audience

This activity was planned to meet the educational needs of pharmacists, physicians, physician assistants, and nurse practitioners involved in the management of patients with type 2 diabetes.

Educational Objectives

At the conclusion of this application-based educational activity, participants should be able to:

  • Review recent clinical trial results supporting the potential for positive glycemic and cardiovascular benefits of diabetes therapies
  • Compare the pharmacokinetics and pharmacodynamics of newer basal insulin formulations with older formulations
  • Compare the clinical profiles of currently available basal insulin products with respect to dosing, variability, volume, and safety

Conflict Of Interest Disclosure Policy

In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their relevant financial relationships. In this activity, only the individuals below have disclosed a relevant financial relationship. No other persons associated with this presentation have disclosed any relevant financial relationships.

Faculty


Susan Cornell, PharmD, CDE, FAADE, FAPhA, Activity Chair

Associate Director of Experiential Education
Associate Professor
Midwestern University Chicago College of Pharmacy
Diabetes Education and Care Provider
Bolingbrook Christian Health Clinic and Will-Grundy Medical Clinic
Downers Grove, IL

Dr. Cornell discloses the following:
Novo Nordisk: advisory board, speakers bureau


Eric L. Johnson, MD

Associate Professor, Department of Family and Community Medicine
Director, Interprofessional Education
University of North Dakota School of Medicine and Health Sciences
Assistant Medical Director, Altru Diabetes Center
Grand Forks, ND

Dr. Johnson discloses the following:
Medtronic: speakers bureau
Novo Nordisk: advisory board, speakers bureau
Sanofi: advisory board

Accredited Provider Disclosure

The planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Society of Health-System Pharmacists designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Instructions

In order to receive credit, participants must complete the pre-assessment, post-test, and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact elearning@ashp.org.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue